2m 2m 2m 2m 2m 2m 2m
PALVELLA THERA (PVLA)
NASDAQ
$142.57+$0.53 (+0.37%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.0BMarket Cap
- 165.89%1-Year Change
- BiotechnologyIndustry
PALVELLA THERA (PVLA)
$142.57+$0.53 (+0.37%)
PVLA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $142.04 | ||
Change | -$0.54 (-0.38%) | ||
Open | $145.55 | ||
High | $146.92 | ||
Low | $138.54 | ||
Previous Close | $142.58 | ||
Volume | 161,872 | ||
30-Day Average Volume | 168,806 | ||
1-Week Change | -9.02% | ||
1-Month Change | -1.32% | ||
1-Year Change | 165.89% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 14.4M | ||
Total Assets | $253.5M | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $1.9M | ||
Net Income | -$21.9M | ||
Free Cash Flow | -$12.8M | ||
EBIT | -$21.9M | ||
EBITDA | -$21.9M | ||
Net Working Capital | $241.1M | ||
EPS | -$1.52 | ||
Enterprise Value/EBITDA | -85 | ||
Enterprise Value/Revenue | 961 | ||
P/B | 9 | ||
P/E | -93 | ||
PEG | 4 | ||
Price/Free Cash Flow | -159 | ||
Price/Operating Cash Flow | -159 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue